Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

Most Recent

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

0 Comments

image: Stubbornly Persistent

Stubbornly Persistent

By | February 1, 2015

Microorganisms continually challenge our assumptions of what life can achieve.

0 Comments

image: The Energy of Life

The Energy of Life

By | February 1, 2015

Extremophiles should not be viewed through an anthropocentric lens; what’s extreme for us may be a perfectly comfortable environment for a microbe.

0 Comments

image: Crystal Structure, Murky Function

Crystal Structure, Murky Function

By | January 29, 2015

Scientists have determined the crystal structures of bacterial translocator proteins, but their functions remain unclear.

0 Comments

image: UV Light Doesn’t Fully Purify

UV Light Doesn’t Fully Purify

By | January 28, 2015

Using ultraviolet light to disinfect drinking water may simply drive bacteria to dormancy, rather than kill them.

0 Comments

image: Interferon Discoverer Dies

Interferon Discoverer Dies

By | January 26, 2015

Jean Lindemann, the virologist who helped figure out that interferons were responsible for anti-viral responses, has passed away at age 90.

0 Comments

image: Human Proteome Mapped Again

Human Proteome Mapped Again

By | January 22, 2015

Researchers complete another interactive protein atlas, boosting the number of publicly available maps of human protein expression levels.

0 Comments

image: GMO “Kill Switches”

GMO “Kill Switches”

By | January 21, 2015

Scientists design bacteria reliant upon synthetic amino acids to contain genetically modified organisms.

5 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Shire Makes $5.2 Billion Buy

Shire Makes $5.2 Billion Buy

By | January 13, 2015

The Irish drugmaker moves on from its terminated sale to AbbVie to purchase New Jersey-based NPS Pharmaceuticals.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement